Ningbo Sansheng Biotechnology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ningbo Sansheng Biotechnology Co., Ltd. - overview
Established
2012
Location
Ningbo, Zhejiang, China
Primary Industry
Agribusiness
About
Founded in 2012 and based in Ningbo, China, Ningbo Sansheng Biotechnology Co. , Ltd. operates as a biotechnology company that focuses on the production and sales of veterinary reproductive hormones. It was recognized as the National High-tech Enterprise.
The company cooperates with universities such as China Agricultural University, South China Agricultural University, and Huazhong Agricultural University. In August 2020, Ningbo Sansheng Biotechnology Co. , Ltd. raised a venture funding for CNY 200 million.
The company is mainly engaged in the production of veterinary reproductive hormones. The products can be divided into two categories: fish and veterinary. The products mainly include allylgestaltenone oral solution, gonadorelin injection, and injection of gonadotropin. The company also promotes batch management technology for sow production and timed insemination technology for large-scale ranches.
The company generates revenue by providing veterinary reproductive hormones.
Current Investors
SDIC Venture Capital, Ningbo Yuren Investment, CoStone Capital
Primary Industry
Agribusiness
Sub Industries
Biotechnology, Pharmaceuticals, Farm Support Services
Website
www.bio-ss.net
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.